Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Ionis Pharmas rare metabolic disorder drug succeeds key study

      Ionis Pharmas rare metabolic disorder drug succeeds key study

      supriya kashyap kashyap23 Dec 2016 12:30 PM IST
      Ionis Pharmaceuticals Inc said its rare metabolic disorder drug for severe hypertriglyceridemia, characterized by elevated levels of a type of fat in...
      NPPA to embark study on Impact analysis of price regulation of essential drugs

      NPPA to embark study on Impact analysis of price regulation of essential drugs

      supriya kashyap kashyap23 Dec 2016 11:11 AM IST
      Mumbai : The National Pharmaceutical Pricing Authority (NPPA) will soon embark on a research study on 'Impact analysis of price regulation in India...
      FDA approves device to replace fingerstick testing for diabetes treatment

      FDA approves device to replace fingerstick testing for diabetes treatment

      supriya kashyap kashyap22 Dec 2016 12:07 PM IST
      The U.S. Food and Drug Administration expanded the approved use of Dexcom’s G5 Mobile Continuous Glucose Monitoring System to allow for replacement of...
      Sun Pharma arm seeks USFDA nod for voluntary withdrawal of 28 ANDAs of Ranbaxy

      Sun Pharma arm seeks USFDA nod for voluntary withdrawal of 28 ANDAs of Ranbaxy

      supriya kashyap kashyap22 Dec 2016 11:26 AM IST
      New Delhi : Drug major Sun Pharma said one of its subsidiaries has voluntarily requested the US health regulator to withdraw approval for 28...
      GSK boosts board-level science as new CEO prepares to take over

      GSK boosts board-level science as new CEO prepares to take over

      supriya kashyap kashyap22 Dec 2016 11:13 AM IST
      Drugmaker GlaxoSmithKline is bolstering scientific expertise on its board by establishing a new science committee, charged with overseeing research,...
      Manufacturing an India specific line of medical devices will increase cost to patient, MTaI board

      Manufacturing an India specific line of medical devices will increase cost to patient, MTaI board

      supriya kashyap kashyap22 Dec 2016 11:12 AM IST
      New Delhi : At a board meeting, members of the Medical Technology Association of India (MTaI) discussed the forecast for 2017 for the medical...
      Jubilant recalls 1.5k bottles of methylprednisolone tablets in US

      Jubilant recalls 1.5k bottles of methylprednisolone tablets in US

      supriya kashyap kashyap22 Dec 2016 11:12 AM IST
      New Delhi : Jubilant Cadista Pharmaceuticals Inc, part of the Jubilant Group, is recalling over 1,500 bottles of glucocorticoid Methylprednisolone...
      Mexico raises cough medicine objection to Sanofi-Boehringer deal

      Mexico raises cough medicine objection to Sanofi-Boehringer deal

      supriya kashyap kashyap21 Dec 2016 12:39 PM IST
      Mexico's antitrust body said it had made local approval of an asset swap between French drugmaker Sanofi and Germany's Boehringer Ingelheim...
      Sun Pharma completes acquisition of 85 percent stake in JSC Biosintez

      Sun Pharma completes acquisition of 85 percent stake in JSC Biosintez

      supriya kashyap kashyap21 Dec 2016 12:39 PM IST
      New Delhi : Drug major Sun Pharmaceutical today said it has completed the acquisition of 85.1 per cent stake in Russia-based JSC Biosintez.All...
      34 percent medical equipment across country dysfunctional: Health Ministry

      34 percent medical equipment across country dysfunctional: Health Ministry

      supriya kashyap kashyap21 Dec 2016 12:38 PM IST
      New Delhi : A massive exercise to map the inventory of all bio-medical equipment, including their functionality status, has revealed that 13-34 per...
      Conatus to receive 50 min Dollars in liver drug deal with Novartis

      Conatus to receive 50 min Dollars in liver drug deal with Novartis

      supriya kashyap kashyap21 Dec 2016 12:37 PM IST
      Swiss drugmaker Novartis said it signed a licensing deal to co-develop a fatty liver disease drug with Conatus Pharmaceuticals Inc, under which the...
      Glenmark Pharma draws up capex of USD 300 mn over next 3 years

      Glenmark Pharma draws up capex of USD 300 mn over next 3 years

      supriya kashyap kashyap21 Dec 2016 12:37 PM IST
      Mumbai : Pharma major Glenmark Pharmaceuticals said it has chalked out USD 300 million capital expenditure plans over the next three years."We will...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok